8-K - SCYNEXIS, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

SCYNEXIS, Inc. entered into a private placement agreement on March 30, 2026, to raise approximately $40.0 million in gross proceeds, with potential for an additional $52.2 million if warrants are fully exercised, extending its estimated cash runway into mid-2029.

Key Takeaways

1The company agreed to issue 34,750,000 shares of common stock and warrants to purchase up to 52,250,000 additional shares to institutional and accredited investors in a private placement.

2Gross proceeds are estimated at $40.0 million upfront, with potential for up to $52.2 million more if all Common Warrants are exercised for cash, subject to stockholder approval.

3The company estimates the net proceeds, combined with existing resources, will fund operations into mid-2029, excluding potential warrant exercise proceeds.

4Each Common Warrant has an exercise price of $1.20 per share and expires on the earlier of the fifth anniversary or 30 days after Week 48 topline data from the Phase 2 study of SCY-770 in ADPKD is released.

5The company entered into a Registration Rights Agreement, committing to file a registration statement within 30 days of closing to register the resale of the securities issued.

6Guggenheim Securities, LLC acted as the sole placement agent, and the company's CEO, Dr. David Angulo, purchased 108,695 shares and accompanying warrants.

Current Report Details

Event Type

Material Agreement+4 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. Private Placement On March 30, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreeme

Material Agreement

$1.20

Source Document

3.02

Unregistered Sales of Equity Securities. The disclosure set forth in Item 1.01 above regarding the Private Placement is incorporated into this Item 3.02. The Sh

Securities Issuance

7.01

, including Exhibit 99.1, shall not be deemed incorporated by reference into any other filing with the SEC made by the Company, whether made before or after the

Regulation Fd

8.01

Other Events. Based on its current plans, the Company estimates that its existing cash, cash equivalents and marketable securities, together with the anticipate

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No.: 4.1 | Description: Form of Pre-Funded Warrant Exhibit No.: 4.2 | Description: Form of Common Warra

Exhibits Only

Source Document

Transaction Details

Material Agreement

Agreement: Securities Purchase Agreement, Registration Rights Agreement
Parties: SCYNEXIS, Inc. and certain investors

•Closing expected on or about April 1, 2026, subject to customary conditions
•Company to file registration statement for resale within 30 days of closing
•Company to seek stockholder approval for share increase within 90 days of closing

Exhibits (6)

10.1

EX-10.1

10.2

EX-10.2

4.1

EX-4.1

4.2

EX-4.2

8-K

99.1

EX-99.1